NYSE - Delayed Quote USD

Enovis Corporation (ENOV)

52.50 +0.79 (+1.53%)
At close: May 14 at 4:00 PM EDT
53.09 +0.59 (+1.12%)
After hours: May 14 at 6:50 PM EDT
Loading Chart for ENOV
DELL
  • Previous Close 51.71
  • Open 52.15
  • Bid --
  • Ask --
  • Day's Range 51.79 - 53.38
  • 52 Week Range 43.04 - 66.14
  • Volume 730,258
  • Avg. Volume 513,924
  • Market Cap (intraday) 2.88B
  • Beta (5Y Monthly) 2.07
  • PE Ratio (TTM) --
  • EPS (TTM) -1.90
  • Earnings Date Aug 1, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 74.10

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

www.enovis.com

6,550

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ENOV

Performance Overview: ENOV

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ENOV
6.28%
S&P 500
10.00%

1-Year Return

ENOV
7.13%
S&P 500
27.22%

3-Year Return

ENOV
27.62%
S&P 500
27.58%

5-Year Return

ENOV
15.10%
S&P 500
86.59%

Compare To: ENOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ENOV

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    2.88B

  • Enterprise Value

    4.23B

  • Trailing P/E

    --

  • Forward P/E

    19.80

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.58

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    2.33

  • Enterprise Value/EBITDA

    27.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.51%

  • Return on Assets (ttm)

    -0.03%

  • Return on Equity (ttm)

    -3.04%

  • Revenue (ttm)

    1.82B

  • Net Income Avi to Common (ttm)

    -103.33M

  • Diluted EPS (ttm)

    -1.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    66.27M

  • Total Debt/Equity (mrq)

    42.68%

  • Levered Free Cash Flow (ttm)

    20.46M

Research Analysis: ENOV

Company Insights: ENOV

Research Reports: ENOV

People Also Watch